Question to the Department for Science, Innovation & Technology:

To ask the Secretary of State for Science, Innovation and Technology, what steps her Department is taking to help increase the level of funding for the pharmaceutical and life sciences sector for clinical trials to (a) optimise existing treatments and (b) support innovation in repurposed drugs for paediatric brain cancer.

The Department for Science, Innovation and Technology invests approximately £200 million into cancer research annually via UK Research and Innovation. In parallel, the Department of Health and Social Care funds cancer research via the National Institute for Health and Care Research, investing £133 million in 2023/24.

The government is supporting commercial clinical research through the Commercial Research Delivery Networks as part of the voluntary scheme for branded medicines pricing, access and growth Investment Programme. Government investment and infrastructure can be used to optimise existing treatments and support innovation in drug repurposing. The forthcoming National Cancer Plan will also detail plans for improving care across all cancer types, including paediatric brain cancers.